What Is Canagliflozin (JNJ 28431754)?

Canagliflozin, also known by its research designation JNJ 28431754, is a small-molecule inhibitor belonging to the gliflozin (flozin) class of compounds. It selectively targets sodium-glucose cotransporter 2 (SGLT2), a membrane transporter predominantly expressed in the S1 and S2 segments of the renal proximal tubule. SGLT2 is responsible for the majority of filtered glucose reabsorption in the kidney; under normal physiological conditions, it reclaims approximately 90% of the glucose filtered at the glomerulus.

By blocking SGLT2 activity, canagliflozin reduces renal glucose reabsorption, leading to increased urinary glucose excretion (glucosuria) and a consequent reduction in circulating blood glucose levels. This insulin-independent mechanism distinguishes SGLT2 inhibitors from other antidiabetic drug classes and makes canagliflozin a particularly valuable pharmacological tool for dissecting glucose homeostasis pathways in research settings.

Mechanism of Action and Selectivity

SGLT2 belongs to the SLC5A gene family of solute carriers. Canagliflozin competitively inhibits SGLT2 by binding within the glucose translocation pathway of the transporter, preventing the cotransport of sodium and glucose across the apical membrane of proximal tubule epithelial cells. The result is a dose-dependent increase in urinary glucose excretion that is independent of insulin secretion or sensitivity.

Selectivity profiling studies have shown that canagliflozin exhibits preference for SGLT2 over the closely related SGLT1 transporter, which is expressed predominantly in the intestinal epithelium and mediates dietary glucose absorption. This selectivity is important in research design: experiments using canagliflozin can isolate renal SGLT2-dependent effects from intestinal SGLT1 contributions, though researchers should be aware that at higher concentrations, some degree of SGLT1 inhibition may occur.

Beyond glucose transport, emerging research suggests canagliflozin may influence additional cellular pathways including AMP-activated protein kinase (AMPK) signaling and mitochondrial function, though these secondary mechanisms remain subjects of active investigation and should be interpreted with appropriate controls in experimental settings.

Research Applications

Diabetes and Metabolic Disease Models: Canagliflozin is widely used in rodent models of type 2 diabetes (T2D), including high-fat diet-induced obesity models and streptozotocin (STZ)-treated animals, to study the consequences of chronic hyperglycemia and to evaluate glucose-lowering strategies independent of the insulin axis. It is a standard pharmacological tool for validating SGLT2 as a therapeutic target and for benchmarking novel compounds.

Renal Physiology Research: Because SGLT2 is the dominant renal glucose transporter, canagliflozin serves as the reference inhibitor in studies examining proximal tubule function, glucosuria thresholds, renal glucose handling, and related tubular transport mechanisms. Researchers studying diabetic nephropathy employ canagliflozin to assess how modulating glucose reabsorption affects glomerular hemodynamics and tubular stress responses.

Cardiovascular and Organ-Protective Research: Observations from clinical and preclinical studies have prompted significant interest in the potential cardioprotective and nephroprotective properties of SGLT2 inhibition. Laboratory research uses canagliflozin to explore mechanisms such as natriuresis, reductions in cardiac preload and afterload, mitochondrial energetics in cardiac tissue, and inflammasome activation, providing mechanistic context for observed organ-protective phenotypes.

In Vitro Studies: In cell-based assays, canagliflozin is applied to SGLT2-expressing cell lines and primary renal tubular cells to investigate transporter kinetics, inhibitor binding, and downstream signaling cascades under controlled conditions.

Handling, Storage, and Preparation Guidelines

Storage: Canagliflozin should be stored as directed on the product datasheet. Small-molecule inhibitors of this class are generally recommended to be stored at -20°C in a desiccated environment, protected from light and moisture, to maintain long-term stability. Researchers should consult the Certificate of Analysis (CoA) accompanying each lot for confirmed purity and specific storage conditions.

Solubility and Vehicle Preparation: Canagliflozin is a lipophilic compound with limited aqueous solubility. It is commonly dissolved in dimethyl sulfoxide (DMSO) to prepare concentrated stock solutions. For cell culture or in vivo applications, the DMSO stock should be further diluted into aqueous buffers or vehicle formulations; final DMSO concentrations should be minimized and appropriate vehicle controls must be included in all experiments. Sonication and gentle warming may assist dissolution. Researchers should verify solubility empirically for each application.

Handling: Standard laboratory precautions for research-grade chemical reagents apply. Avoid repeated freeze-thaw cycles; it is advisable to prepare single-use aliquots from the stock solution. Personnel should consult the Safety Data Sheet (SDS) prior to use.

Purity: Aladdin Scientific supplies Canagliflozin (C126191) as a research-grade reagent. Purity specifications are confirmed by HPLC or equivalent analytical methods and are documented in the CoA. Researchers requiring specific purity thresholds should request the CoA prior to experimental use.

Why Choose Aladdin Scientific Canagliflozin?

Aladdin Scientific's Canagliflozin (JNJ 28431754), catalog number C126191, is manufactured and quality-controlled to meet the rigorous demands of modern biomedical research. Each lot is characterized for identity, purity, and potency to ensure reproducible results across experiments. Researchers benefit from reliable batch-to-batch consistency, transparent documentation through Certificates of Analysis, and dedicated technical support.

As a trusted supplier of research reagents to academic, pharmaceutical, and biotechnology laboratories worldwide, Aladdin Scientific is committed to providing high-quality small-molecule inhibitors that enable meaningful scientific discovery. For bulk quantities, custom formulations, or application-specific inquiries regarding Canagliflozin, customers are encouraged to contact Aladdin Scientific's technical and sales teams directly.